» Articles » PMID: 8339250

Transcriptional Control of Estrogen Receptor in Estrogen Receptor-negative Breast Carcinoma

Overview
Journal Cancer Res
Specialty Oncology
Date 1993 Aug 1
PMID 8339250
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms which control estrogen receptor (ER) expression in breast carcinoma have not been elucidated. The MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) breast carcinoma cell lines have been used to examine ER gene expression. Northern blot analysis of mRNA isolated from these two cell lines demonstrates that MCF-7 cells express an expected 6.5-kilobase ER mRNA whereas MDA-MB-231 do not make detectable ER message. Reverse polymerase chain reaction, which offers greater sensitivity, confirms these Northern blot results. The nuclear run-on assay was used to examine directly transcription in these two cell lines. MCF-7 cells actively transcribe the ER gene whereas no ER transcription is detected in MDA-MB-231. Southern analysis of genomic DNA confirms that the ER gene is present in MDA-MB-231. We conclude that the ER gene is controlled transcriptionally in this ER-negative breast carcinoma line.

Citing Articles

A Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer.

Wu V, Kiriazov B, Koch K, Gu V, Beck A, Borcherding N Mol Cancer Res. 2019; 18(1):46-56.

PMID: 31619506 PMC: 6942205. DOI: 10.1158/1541-7786.MCR-19-0359.


Black-White Disparities in Breast Cancer Subtype: The Intersection of Socially Patterned Stress and Genetic Expression.

Linnenbringer E, Gehlert S, Geronimus A AIMS Public Health. 2018; 4(5):526-556.

PMID: 29333472 PMC: 5764177. DOI: 10.3934/publichealth.2017.5.526.


3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios C Ann Oncol. 2017; 28(1):16-33.

PMID: 28177437 PMC: 5378224. DOI: 10.1093/annonc/mdw544.


The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancer.

Zhang W, Chang Z, Shi K, Song L, Cui L, Ma Z Oncol Lett. 2016; 11(3):1995-2000.

PMID: 26998112 PMC: 4774582. DOI: 10.3892/ol.2016.4193.


Circadian disruption and breast cancer: an epigenetic link?.

Kochan D, Kovalchuk O Oncotarget. 2015; 6(19):16866-82.

PMID: 26220712 PMC: 4627279. DOI: 10.18632/oncotarget.4343.